Dianthus Therapeutics, Inc.

The current price of DNTH is 22.53 USD — it has increased by 5.53% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Dianthus Therapeutics, Inc. stocks are traded under the ticker DNTH.

Dianthus Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

DNTH stock is 9.40% volatile and has beta coefficient of 0.81. Check out the list of the most volatile stocks — is Dianthus Therapeutics, Inc. there?

DNTH earnings for the last quarter are −3.78 USD per share, whereas the estimation was −0.56 USD resulting in a −575.00% surprise. The estimated earnings for the next quarter are −0.94 USD per share. See more details about Dianthus Therapeutics, Inc. earnings.

Dianthus Therapeutics, Inc. revenue for the last quarter amounts to ‪924.00 K‬ USD despite the estimated figure of ‪250.00 K‬ USD. In the next quarter revenue is expected to reach ‪548.50 K‬ USD.

Yes, you can track Dianthus Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

DNTH stock has fallen by 3.64% compared to the previous week, the month change is a 24.62% fall, over the last year Dianthus Therapeutics, Inc. has showed a 82.80% increase.

Today Dianthus Therapeutics, Inc. has the market capitalization of ‪626.55 M‬, it has decreased by 3.73% over the last week.

No, DNTH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, DNTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dianthus Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

DNTH reached its all-time high on Mar 26, 2019 with the price of 336.00 USD, and its all-time low was 5.14 USD and was reached on Dec 21, 2022.
See other stocks reaching their highest and lowest prices.

As of May 1, 2024, the company has 53.00 employees. See our rating of the largest employees — is Dianthus Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Dianthus Therapeutics, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Dianthus Therapeutics, Inc. stock shows the neutral signal. See more of Dianthus Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Dianthus Therapeutics, Inc. future price: according to them, DNTH price has a max estimate of 84.00 USD and a min estimate of 33.00 USD. Read a more detailed Dianthus Therapeutics, Inc. forecast: see what analysts think of Dianthus Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Dianthus Therapeutics, Inc. EBITDA is ‪−46.97 M‬ USD, and current EBITDA margin is ‪−1.69 K‬%. See more stats in Dianthus Therapeutics, Inc. financial statements.